Method2 | ||||||
---|---|---|---|---|---|---|
Ag | Peptide # | Peptide sequence1 | Reference segment3 | Method of extension4 | Area of extension5 | A450 nm for serum diluted 1:10 0006 |
IA-2 | 1 | VSSQFSDAAQASPS | B | 1.75 | ||
2 | SPSSHSSTPSWCEEP | B | 0.30 | |||
3 | RYWPDEGASLYHVYEV | B | 0.36 | |||
4 | ALTAVAEEVNAILKALPQ | L | FPS | - | 3.62 | |
5 | NAILKALPQVKEIDLTAE | L | NN | CC | 0.14 | |
6 | qplaklianeatledksr | L | NNd | CC | 0.02 | |
7 | diekvgkaGPGNAILKALPQ | L | MD | CC | 0.02 | |
8 | ARIKLKVESSPSRSDYIN | T | FPS | SC | 1.83 | |
TPO | 9 | VVTDDDRYSDLLMAWGQ | B | 3.76 | ||
10 | ARLRDSGRAYLPFVPP | B | 0.46 | |||
11 | PYEGYDSTANPTVSNVF | B | 0.06 | |||
12 | EDFESCDSIPGMNLEA | B | 0.39 | |||
13 | RRLDASFQEHPDLPGLWLH | L | FPS | - | 3.75 | |
14 | ASFQEHPDLPGRLWQFVLS | L | NN | CC | 0.33 | |
15 | APEPGIPGERPCPPRAPAA | T | NN | TC | 0.47 | |
16 | ASFQEHPDLPGRAPEPGIPGE | L | MD | CC | 0.14 | |
IL8 | 17 | PKFIKELRVIESGPHCANT | L | FPS | - | 0.16 |
18 | ENWVQRVVEKFLKRAENS | T | FPS | SC | 2.25 |